Breaking News Instant updates and real-time market news.

MESO

Mesoblast

$7.96 /

-0.06 (-0.75%)

06:09
01/15/20
01/15
06:09
01/15/20
06:09

Mesoblast announces Ryoncil as brand name for first planned U.S. product launch

Mesoblast reported that the U.S. FDA has agreed to the selection of Ryoncil as the commercial name for its lead allogeneic cell therapy remestemcel-L in the treatment of pediatric steroid-refractory acute graft versus host disease. Commercial plans for Ryoncil were presented at the 2020 Biotech Showcase being held this week in San Francisco, CA. The final module of the rolling Biologics License Application for Ryoncil will be filed with the FDA in January, following which the company will request a priority FDA review of the BLA under the product candidate's existing Fast Track designation. If approved, Ryoncil is planned to be launched in the U.S. in 2020.

MESO Mesoblast
$7.96 /

-0.06 (-0.75%)

01/31/19 HCWC
Mesoblast assumed with a Buy at H.C. Wainwright
09/10/19 CANT
Mesoblast partnership deal with Grunenthal a positive, says Cantor Fitzgerald
10/22/19 CANT
Mesoblast assumed with an Overweight at Cantor Fitzgerald

TODAY'S FREE FLY STORIES

Earnings
ConnectOne Bancorp reports Q4 adjusted EPS 61c, consensus 62c » 07:05
01/23/20
01/23
07:05
01/23/20
07:05
CNOB

ConnectOne Bancorp

$25.30 /

+0.07 (+0.28%)

As of December 31, 2019,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
JetBlue reports Q4 RASM down 2.7% y/y, CASM ex-fuel flat y/y » 07:05
01/23/20
01/23
07:05
01/23/20
07:05
JBLU

JetBlue

$19.80 /

+0.71 (+3.72%)

Fourth quarter 2019…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Procter & Gamble reports Q2 core EPS $1.42, consensus $1.37 » 07:05
01/23/20
01/23
07:05
01/23/20
07:05
PG

Procter & Gamble

$125.56 /

+0.2 (+0.16%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
JetBlue reports Q4 adjusted EPS 56c, consensus 55c » 07:04
01/23/20
01/23
07:04
01/23/20
07:04
JBLU

JetBlue

$19.80 /

+0.71 (+3.72%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
BNY Mellon management to meet with UBS » 07:04
01/23/20
01/23
07:04
01/23/20
07:04
BK

BNY Mellon

$46.73 /

-0.05 (-0.11%)

Meeting to be held in New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Abbott price target raised to $104 from $95 at Stifel » 07:03
01/23/20
01/23
07:03
01/23/20
07:03
ABT

Abbott

$91.95 /

+2.19 (+2.44%)

Following Abbott's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Sito Mobile names Scott Kauffman as Interim CEO » 07:03
01/23/20
01/23
07:03
01/23/20
07:03
SITO

Sito Mobile

$0.27 /

-0.0155 (-5.52%)

Sito Mobile announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
EyePoint sees FY19 revenues $19.3M-$20M, consensus $17.9M » 07:03
01/23/20
01/23
07:03
01/23/20
07:03
EYPT

EyePoint

$1.60 /

-0.04 (-2.44%)

"2019 was a year…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
TTM Technologies price target raised to $18 from $16 at SunTrust » 07:02
01/23/20
01/23
07:02
01/23/20
07:02
TTMI

TTM Technologies

$15.23 /

-0.215 (-1.39%)

SunTrust analyst William…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
EyePoint sees Q4 revenues $7.5M-$8.2M, consensus $6.18M » 07:02
01/23/20
01/23
07:02
01/23/20
07:02
EYPT

EyePoint

$1.60 /

-0.04 (-2.44%)

For the fourth quarter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Travelers reports adj. book value per share $92.76, up 6% y/y » 07:01
01/23/20
01/23
07:01
01/23/20
07:01
TRV

Travelers

$141.39 /

+0.51 (+0.36%)

Reports book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Karuna Therapeutics 2.1M share Block Trade priced at $99.75 » 07:00
01/23/20
01/23
07:00
01/23/20
07:00
KRTX

Karuna Therapeutics

$115.97 /

+7.14 (+6.56%)

Goldman Sachs acted as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
European stock markets are mostly lower, » 07:00
01/23/20
01/23
07:00
01/23/20
07:00

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FX Update: Sentiment remained fickle » 07:00
01/23/20
01/23
07:00
01/23/20
07:00

FX Update: Sentiment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Oil Action: Front-month WTI futures are down 1.7% » 07:00
01/23/20
01/23
07:00
01/23/20
07:00

Oil Action: Front-month…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Travelers reports Q4 consolidated combined ratio of 92.4% » 06:59
01/23/20
01/23
06:59
01/23/20
06:59
TRV

Travelers

$141.39 /

+0.51 (+0.36%)

Fourth quarter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
VF Corp. lowers FY20 adj EPS view to $3.30 from $3.32-$3.37, consensus $3.37 » 06:59
01/23/20
01/23
06:59
01/23/20
06:59
VFC

VF Corp.

$94.55 /

-0.08 (-0.08%)

Lowers FY20 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Travelers reports Q4 core EPS $3.32, consensus $3.29 » 06:58
01/23/20
01/23
06:58
01/23/20
06:58
TRV

Travelers

$141.39 /

+0.51 (+0.36%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Travelers reports Q4 core EPS $3.32, consensus $3.29  06:57
01/23/20
01/23
06:57
01/23/20
06:57
TRV

Travelers

$141.39 /

+0.51 (+0.36%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Morgan Stanley upgrades Micron, Western Digital on memory pricing strength » 06:57
01/23/20
01/23
06:57
01/23/20
06:57
MU

Micron

$59.17 /

+0.2 (+0.34%)

, WDC

Western Digital

$68.67 /

-0.12 (-0.17%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Zomedica says plans to focus on TRUFORMA commercialization » 06:56
01/23/20
01/23
06:56
01/23/20
06:56
ZOM

Zomedica

$0.29 /

-0.0198 (-6.49%)

Zomedica announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
VF Corp. reports Q3 adjusted EPS $1.23, consensus $1.21 » 06:56
01/23/20
01/23
06:56
01/23/20
06:56
VFC

VF Corp.

$94.55 /

-0.08 (-0.08%)

Reports Q3 revenue $3.4B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Apple price target raised to $340 from $330 at BofA » 06:54
01/23/20
01/23
06:54
01/23/20
06:54
AAPL

Apple

$317.85 /

+1.46 (+0.46%)

BofA analyst Wamsi Mohan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Pfizer's Greenstone to provide generic Viagra to digital men's health clinic » 06:54
01/23/20
01/23
06:54
01/23/20
06:54
PFE

Pfizer

$40.19 /

-0.17 (-0.42%)

Pfizer's wholly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
MGM Resorts price target raised to $40 from $37 at Barclays » 06:52
01/23/20
01/23
06:52
01/23/20
06:52
MGM

MGM Resorts

$31.95 /

-0.42 (-1.30%)

Barclays analyst Felicia…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.